BCL2 and glioblastoma: Serially diluted treatment of highly sensitive GBM cell lines (Onda7, DK-MG, and YH-13) with different Bcl-2 family inhibitors revealed that obatoclax exhibited significantly higher growth inhibitory effects than did navitoclax and venetoclax (Fig. 1C).